"Antivir Chem Chemother"[ Journal] - Search Results

Year	Number of Results
1998	51
1999	32
2000	38
2001	53
2002	35
2003	34
2004	33
2005	36
2006	30
2007	32
2008	14
2009	21
2010	22
2011	26
2012	16
2013	4
2014	12
2015	20
2017	11
2018	19
2019	5
2020	14
2021	9
2022	6
2023	2
2024	0

1

The continuing need for therapeutic agents for respiratory syncytial virus infection.

Roberts NJ Jr. Roberts NJ Jr. Antivir Chem Chemother. 2023 Jan-Dec;31:20402066231194424. doi: 10.1177/20402066231194424. Antivir Chem Chemother. 2023. PMID: 37574755 Free PMC article.

2

The development of BVDU: An odyssey.

De Clercq E. De Clercq E. Antivir Chem Chemother. 2023 Jan-Dec;31:20402066231152971. doi: 10.1177/20402066231152971. Antivir Chem Chemother. 2023. PMID: 36710501 Free PMC article. Review.

3

Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens.

Gish RG, Asselah T, Squires K, Mayers D. Gish RG, et al. Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221138705. doi: 10.1177/20402066221138705. Antivir Chem Chemother. 2022. PMID: 36423233 Free PMC article. Review.

4

Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation).

Clercq E. Clercq E. Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221129979. doi: 10.1177/20402066221129979. Antivir Chem Chemother. 2022. PMID: 36305032 Free PMC article. Review.

5

Meeting report: 34th international conference on antiviral research.

Brancale A, Carter K, Delang L, Deval J, Durantel D, Gentry BG, Jordan R, Julander JG, Lo MK, Pérez-Pérez MJ, Schang LM, Seley-Radtke KL, Shi PY, Vasudevan SG, Whitley RJ, Spengler JR. Brancale A, et al. Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221130853. doi: 10.1177/20402066221130853. Antivir Chem Chemother. 2022. PMID: 36305015 Free PMC article.

6

Efficacy of oleandrin and PBI-05204 against bovine viruses of importance to commercial cattle health.

Newman RA, Chase CCL, Matos JR, Abdelsalam K, Buterbaugh R, Van Holland S, Abdelaal H, Woolum A, Jagannadha Sastry K. Newman RA, et al. Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221103960. doi: 10.1177/20402066221103960. Antivir Chem Chemother. 2022. PMID: 35611441 Free PMC article.

7

New composition of tungsten has a broad range of antiviral activity.

Avagyan H, Mirzoyan A, Mirzoyan F, Izmailyan R, Hakobyan S, Voskanyan H, Semerjyan Z, Avetisyan A, Arzumanyan H, Karalova E, Abroyan L, Hakobyan L, Bayramyan N, Gevorgyan N, Karalyan A, Karalyan Z. Avagyan H, et al. Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221090061. doi: 10.1177/20402066221090061. Antivir Chem Chemother. 2022. PMID: 35392696 Free PMC article.

8

Activity of 3,19-isopropylidinyl andrographolide against herpes simplex virus type 1 in an animal model.

Chuerduangphui J, Nukpook T, Pientong C, Aromdee C, Suebsasana S, Khunkitti W, So-In C, Proyrungroj K, Ekalaksananan T. Chuerduangphui J, et al. Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221089724. doi: 10.1177/20402066221089724. Antivir Chem Chemother. 2022. PMID: 35379009 Free PMC article.

9

Anti-influenza virus activity of the elenolic acid rich olive leaf (Olea europaea L.) extract Isenolic^®.

Salamanca A, Almodóvar P, Jarama I, González-Hedström D, Prodanov M, Inarejos-García AM. Salamanca A, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211063391. doi: 10.1177/20402066211063391. Antivir Chem Chemother. 2021. PMID: 34839747 Free PMC article.

10

Clinical severe acute respiratory syndrome coronavirus 2 isolation and antiviral testing.

Mathez G, Cagno V. Mathez G, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211061063. doi: 10.1177/20402066211061063. Antivir Chem Chemother. 2021. PMID: 34806440 Free PMC article.

11

Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies.

Dycke JV, Rymenants J, Neyts J, Rocha-Pereira J. Dycke JV, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211025175. doi: 10.1177/20402066211025175. Antivir Chem Chemother. 2021. PMID: 34525875 Free PMC article.

12

Insights into bioinformatic approaches for repurposing compounds as anti-viral drugs.

Zheng W, D'Aiuto L, Demers MJ, Muralidaran V, Wood JA, Wesesky M, Chattopadhyay A, Nimgaonkar VL. Zheng W, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211036822. doi: 10.1177/20402066211036822. Antivir Chem Chemother. 2021. PMID: 34463534 Free PMC article.

13

Screening and in vitro antiviral assessment of small molecules against fluorescent protein-expressing Bunyamwera virus in a cell-based assay using high-content imaging.

Ter Horst S, Chiu W, Neyts J, Rocha-Pereira J. Ter Horst S, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211033478. doi: 10.1177/20402066211033478. Antivir Chem Chemother. 2021. PMID: 34378414 Free PMC article.

14

V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens.

Lewis ME, Simpson P, Mori J, Jubb B, Sullivan J, McFadyen L, van der Ryst E, Craig C, Robertson DL, Westby M. Lewis ME, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211030380. doi: 10.1177/20402066211030380. Antivir Chem Chemother. 2021. PMID: 34343443 Free PMC article.

15

Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Identification of active compounds.

Van Dycke J, Rymenants J, Neyts J, Rocha-Pereira J. Van Dycke J, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211026852. doi: 10.1177/20402066211026852. Antivir Chem Chemother. 2021. PMID: 34187186 Free PMC article.

16

Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maraviroc.

Lewis ME, Jubb B, Simpson P, Lopatukhin A, Kireev D, Bobkova M, Craig C, van der Ryst E, Westby M, Butler SL. Lewis ME, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211025156. doi: 10.1177/20402066211025156. Antivir Chem Chemother. 2021. PMID: 34160290 Free PMC article.

17

Killing HIV-infected resting central memory CD4⁺ T cells by targeting inhibitor of apoptosis proteins-inhibited autophagy.

Zhang G, Huang X. Zhang G, et al. Antivir Chem Chemother. 2021 Jan-Dec;29:2040206620980888. doi: 10.1177/2040206620980888. Antivir Chem Chemother. 2021. PMID: 33557588 Free PMC article.

18

Memantine treatment reduces the incidence of flaccid paralysis in a zika virus mouse model of temporary paralysis with similarities to Guillain-Barré syndrome.

Siddharthan V, Wang H, de Oliveira AL, Dai X, Morrey JD. Siddharthan V, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620950143. doi: 10.1177/2040206620950143. Antivir Chem Chemother. 2020. PMID: 34161179 Free PMC article.

19

Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective.

Ogunyemi OM, Gyebi GA, Elfiky AA, Afolabi SO, Ogunro OB, Adegunloye AP, Ibrahim IM. Ogunyemi OM, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620984076. doi: 10.1177/2040206620984076. Antivir Chem Chemother. 2020. PMID: 33372806 Free PMC article.

20

Gallium maltolate has in vitro antiviral activity against SARS-CoV-2 and is a potential treatment for COVID-19.

Bernstein LR, Zhang L. Bernstein LR, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620983780. doi: 10.1177/2040206620983780. Antivir Chem Chemother. 2020. PMID: 33353394 Free PMC article.

21

Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections.

Huchting J. Huchting J. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620976786. doi: 10.1177/2040206620976786. Antivir Chem Chemother. 2020. PMID: 33297724 Free PMC article. Review.

22

Real-world single-center experience with direct-acting antivirals for improvement of the liver fibrosis after chronic hepatitis C treatment.

Lee SH, Shin HP, Lee JI. Lee SH, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620974835. doi: 10.1177/2040206620974835. Antivir Chem Chemother. 2020. PMID: 33215505 Free PMC article.

23

Small molecule antivirals - Still our best hope for a cure.

Seley-Radtke K. Seley-Radtke K. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620963964. doi: 10.1177/2040206620963964. Antivir Chem Chemother. 2020. PMID: 33153278 Free PMC article. No abstract available.

24

Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond.

Poddighe D, Aljofan M. Poddighe D, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620961712. doi: 10.1177/2040206620961712. Antivir Chem Chemother. 2020. PMID: 32972196 Free PMC article.

25

Spectrum of antiviral activity of 4-aminopyrimidine N-oxides against a broad panel of tick-borne encephalitis virus strains.

Dueva EV, Tuchynskaya KK, Kozlovskaya LI, Osolodkin DI, Sedenkova KN, Averina EB, Palyulin VA, Karganova GG. Dueva EV, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620943462. doi: 10.1177/2040206620943462. Antivir Chem Chemother. 2020. PMID: 32811155 Free PMC article.

26

Respiratory syntycial virus: Current treatment strategies and vaccine approaches.

Thornhill EM, Salpor J, Verhoeven D. Thornhill EM, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620947303. doi: 10.1177/2040206620947303. Antivir Chem Chemother. 2020. PMID: 32741202 Free PMC article. Review.

27

Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting.

Chehadeh W, Albaksami O, Al-Shammari S. Chehadeh W, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620927908. doi: 10.1177/2040206620927908. Antivir Chem Chemother. 2020. PMID: 32434393 Free PMC article.

28

Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review.

Abd El Aziz MA, Sacco R, Facciorusso A. Abd El Aziz MA, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620921331. doi: 10.1177/2040206620921331. Antivir Chem Chemother. 2020. PMID: 32418480 Free PMC article. Review.

29

Application of human lymphoid cells for the evaluation of antivirals against human adenovirus type 19: Zalcitabine has superior activity compared to cidofovir.

Nakagawara K, Hayashi H, Kawaji K, Sasano M, Kodama EN. Nakagawara K, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620921319. doi: 10.1177/2040206620921319. Antivir Chem Chemother. 2020. PMID: 32345035 Free PMC article.

30

In vitro anti-adenoviral activities of ethanol extract, fractions, and main phenolic compounds of pomegranate (Punica granatum L.) peel.

Karimi A, Moradi MT, Rabiei M, Alidadi S. Karimi A, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620916571. doi: 10.1177/2040206620916571. Antivir Chem Chemother. 2020. PMID: 32306749 Free PMC article.

31

Genome analysis of coxsackievirus B1 isolates during the consecutive alternating administration course of triple antiviral combination in newborn mice.

Grozdanov P, Joffret ML, Stoyanova A, Polston P, Achouri E, Nikolova I, Delpeyroux F, Galabov AS. Grozdanov P, et al. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620906061. doi: 10.1177/2040206620906061. Antivir Chem Chemother. 2020. PMID: 32041425 Free PMC article.

32

Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.

Jubb B, Lewis M, McFadyen L, Simpson P, Mori J, Chan P, Weatherley B, van der Ryst E, Westby M, Craig C. Jubb B, et al. Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619895706. doi: 10.1177/2040206619895706. Antivir Chem Chemother. 2019. PMID: 31856576 Free PMC article. Clinical Trial.

33

Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.

Di Palma F, Daino GL, Ramaswamy VK, Corona A, Frau A, Fanunza E, Vargiu AV, Tramontano E, Ruggerone P. Di Palma F, et al. Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619889220. doi: 10.1177/2040206619889220. Antivir Chem Chemother. 2019. PMID: 31744306 Free PMC article.

34

Synthesis and anti-human immunodeficiency virus activity of substituted ( o,o-difluorophenyl)-linked-pyrimidines as potent non-nucleoside reverse transcriptase inhibitors.

Čechová L, Dejmek M, Baszczyňski O, Šaman D, Gao L, Hu E, Stepan G, Jansa P, Janeba Z, Šimon P. Čechová L, et al. Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619826265. doi: 10.1177/2040206619826265. Antivir Chem Chemother. 2019. PMID: 30788976 Free PMC article.

35

Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration.

De Clercq E. De Clercq E. Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619829382. doi: 10.1177/2040206619829382. Antivir Chem Chemother. 2019. PMID: 30776910 Free PMC article. Review.

36

A medium-throughput screen for inhibitors of human metapneumovirus.

Becker JC, Tollefson SJ, Weaver D, Williams JV. Becker JC, et al. Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619830197. doi: 10.1177/2040206619830197. Antivir Chem Chemother. 2019. PMID: 30759993 Free PMC article.

37

Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus.

Baszczyňski O, Kaiser MM, Česnek M, Břehová P, Jansa P, Procházková E, Dračínský M, Snoeck R, Andrei G, Janeba Z. Baszczyňski O, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618813050. doi: 10.1177/2040206618813050. Antivir Chem Chemother. 2018. PMID: 30497281 Free PMC article.

38

Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells.

Boltz D, Peng X, Muzzio M, Dash P, Thomas PG, Margitich V. Boltz D, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618811416. doi: 10.1177/2040206618811416. Antivir Chem Chemother. 2018. PMID: 30466301 Free PMC article.

39

Cyclophilin A as a target in the treatment of cytomegalovirus infections.

A Abdullah A, Abdullah R, A Nazariah Z, N Balakrishnan K, Firdaus J Abdullah F, A Bala J, Mohd-Lila MA. A Abdullah A, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618811413. doi: 10.1177/2040206618811413. Antivir Chem Chemother. 2018. PMID: 30449131 Free PMC article. Review.

40

The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.

Franco EJ, Rodriquez JL, Pomeroy JJ, Hanrahan KC, Brown AN. Franco EJ, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618807580. doi: 10.1177/2040206618807580. Antivir Chem Chemother. 2018. PMID: 30354193 Free PMC article.

41

Corrigendum.

[No authors listed] [No authors listed] Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618790862. doi: 10.1177/2040206618790862. Antivir Chem Chemother. 2018. PMID: 30016878 Free PMC article.

42

Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA.

Vere Hodge RA. Vere Hodge RA. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618783924. doi: 10.1177/2040206618783924. Antivir Chem Chemother. 2018. PMID: 29954186 Free PMC article.

43

Advances in antiviral nucleoside analogues and their prodrugs.

Seley-Radtke K, Deval J. Seley-Radtke K, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618781410. doi: 10.1177/2040206618781410. Antivir Chem Chemother. 2018. PMID: 29890841 Free PMC article. No abstract available.

44

Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.

Slusarczyk M, Serpi M, Pertusati F. Slusarczyk M, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618775243. doi: 10.1177/2040206618775243. Antivir Chem Chemother. 2018. PMID: 29792071 Free PMC article. Review.

45

Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.

Boukhvalova MS, Yim KC, Blanco J. Boukhvalova MS, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618770518. doi: 10.1177/2040206618770518. Antivir Chem Chemother. 2018. PMID: 29768937 Free PMC article. Review.

46

Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa.

Penrose KJ, Brumme CJ, Scoulos-Hanson M, Hamanishi K, Gordon K, Viana RV, Wallis CL, Harrigan PR, Mellors JW, Parikh UM. Penrose KJ, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618762985. doi: 10.1177/2040206618762985. Antivir Chem Chemother. 2018. PMID: 29566538 Free PMC article.

47

Nucleosides for the treatment of respiratory RNA virus infections.

Jordan PC, Stevens SK, Deval J. Jordan PC, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618764483. doi: 10.1177/2040206618764483. Antivir Chem Chemother. 2018. PMID: 29562753 Free PMC article. Review.

48

Characterization of phenyl pyrimidine derivatives that inhibit cytomegalovirus immediate-early gene expression.

Yamada KH, Majima R, Yamaguchi T, Inoue N. Yamada KH, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618763193. doi: 10.1177/2040206618763193. Antivir Chem Chemother. 2018. PMID: 29546767 Free PMC article.

49

Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.

Eyer L, Nencka R, de Clercq E, Seley-Radtke K, Růžek D. Eyer L, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618761299. doi: 10.1177/2040206618761299. Antivir Chem Chemother. 2018. PMID: 29534608 Free PMC article. Review.

50

Addressing the selectivity and toxicity of antiviral nucleosides.

Feng JY. Feng JY. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618758524. doi: 10.1177/2040206618758524. Antivir Chem Chemother. 2018. PMID: 29534607 Free PMC article. Review.

51

Flexibility-Not just for yoga anymore!

Seley-Radtke K. Seley-Radtke K. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618756788. doi: 10.1177/2040206618756788. Antivir Chem Chemother. 2018. PMID: 29466861 Free PMC article. Review.

52

Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection.

Dousson CB. Dousson CB. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618756430. doi: 10.1177/2040206618756430. Antivir Chem Chemother. 2018. PMID: 29463095 Free PMC article. Review.

53

Synthesis and substrate properties towards HIV-1 reverse transcriptase of new diphosphate analogues of 9-[(2-phosphonomethoxy)ethyl]adenine.

Laux WH, Priet S, Alvarez K, Peyrottes S, Périgaud C. Laux WH, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618757636. doi: 10.1177/2040206618757636. Antivir Chem Chemother. 2018. PMID: 29436843 Free PMC article.

54

Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.

Famiglini V, Silvestri R. Famiglini V, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206617753443. doi: 10.1177/2040206617753443. Antivir Chem Chemother. 2018. PMID: 29417826 Free PMC article. Review.

55

Polarized macrophage subsets differentially express the drug efflux transporters MRP1 and BCRP, resulting in altered HIV production.

He H, Buckley M, Britton B, Mu Y, Warner K, Kumar S, Cory TJ. He H, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206617745168. doi: 10.1177/2040206617745168. Antivir Chem Chemother. 2018. PMID: 29343083 Free PMC article.

56

3,7-Dideazaneplanocin: Synthesis and antiviral analysis.

Yin XQ, Schneller SW. Yin XQ, et al. Antivir Chem Chemother. 2017 Dec;25(3):90-93. doi: 10.1177/2040206617742561. Antivir Chem Chemother. 2017. PMID: 29172646 Free PMC article.

57

Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors.

Baba M, Toyama M, Sakakibara N, Okamoto M, Arima N, Saijo M. Baba M, et al. Antivir Chem Chemother. 2017 Dec;25(3):83-89. doi: 10.1177/2040206617740303. Epub 2017 Nov 3. Antivir Chem Chemother. 2017. PMID: 29096526 Free PMC article.

58

Nucleoside diphosphate and triphosphate prodrugs - An unsolvable task?

Meier C. Meier C. Antivir Chem Chemother. 2017 Dec;25(3):69-82. doi: 10.1177/2040206617738656. Epub 2017 Nov 3. Antivir Chem Chemother. 2017. PMID: 29096525 Free PMC article. Review.

59

Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz.

Jordaan MA, Shapi M. Jordaan MA, et al. Antivir Chem Chemother. 2017 Dec;25(3):94-104. doi: 10.1177/2040206617730170. Epub 2017 Sep 11. Antivir Chem Chemother. 2017. PMID: 28893089 Free PMC article.

60

Cycluridine: A novel antiviral effective against flaviviruses.

Galabov AS, Mukova L, Abashev YP, Wassilewa L, Tzvetkov P, Minkov V, Barinskiy IF, Rice CM, Ouzounov S, Sidzhakova D. Galabov AS, et al. Antivir Chem Chemother. 2017 Aug;25(2):58-67. doi: 10.1177/2040206617723442. Antivir Chem Chemother. 2017. PMID: 28768435 Free PMC article. Review.

61

Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities.

Masson JJ, Billings HW, Palmer CS. Masson JJ, et al. Antivir Chem Chemother. 2017 Aug;25(2):53-57. doi: 10.1177/2040206617701372. Antivir Chem Chemother. 2017. PMID: 28768434 Free PMC article. Review.

62

Editorial.

Brancale A. Brancale A. Antivir Chem Chemother. 2017 Aug;25(2):19. doi: 10.1177/2040206617724304. Antivir Chem Chemother. 2017. PMID: 28768433 Free PMC article. No abstract available.

63

Potential of small-molecule fungal metabolites in antiviral chemotherapy.

Roy BG. Roy BG. Antivir Chem Chemother. 2017 Aug;25(2):20-52. doi: 10.1177/2040206617705500. Epub 2017 Jul 23. Antivir Chem Chemother. 2017. PMID: 28737040 Free PMC article. Review.

64

Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.

Baloch K, Chen L, Memon AA, Dexter L, Irving W, Ilyas M, Thomson BJ. Baloch K, et al. Antivir Chem Chemother. 2017 Apr;25(1):2-10. doi: 10.1177/2040206616686894. Epub 2017 Jan 1. Antivir Chem Chemother. 2017. PMID: 28417642 Free PMC article.

65

Editorial for AVCC relaunch issue.

Brancale A. Brancale A. Antivir Chem Chemother. 2017 Apr;25(1):1. doi: 10.1177/2040206617704930. Antivir Chem Chemother. 2017. PMID: 28417641 Free PMC article. No abstract available.

66

Combinations of L-N^G-monomethyl-arginine and oseltamivir against pandemic influenza A virus infections in mice.

Smee DF, Dagley A, Tarbet EB. Smee DF, et al. Antivir Chem Chemother. 2017 Apr;25(1):11-17. doi: 10.1177/2040206617691885. Epub 2017 Mar 21. Antivir Chem Chemother. 2017. PMID: 28417640 Free PMC article.

67

Synthesis of multi ring-fused imidazo [1,2- a]isoquinoline-based fluorescent scaffold as anti-Herpetic agent.

Chakravarty H, Ojha D, Konreddy AK, Bal C, Chandra NS, Sharon A, Chattopadhyay D. Chakravarty H, et al. Antivir Chem Chemother. 2015 Dec;24(5-6):127-135. doi: 10.1177/2040206616680968. Antivir Chem Chemother. 2015. PMID: 30889631 Free PMC article.

68

Novel symmetrical phenylenediamines as potential anti-hepatitis C virus agents.

Bassetto M, Ferla S, Leyssen P, Neyts J, Yerukhimovich MM, Frick DN, O'Donnell R, Brancale A. Bassetto M, et al. Antivir Chem Chemother. 2015 Dec;24(5-6):155-160. doi: 10.1177/2040206616676353. Epub 2016 Nov 4. Antivir Chem Chemother. 2015. PMID: 27815332 Free PMC article.

69

Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.

Stoyanova A, Nikolova I, Pürstinger G, Dobrikov G, Dimitrov V, Philipov S, Galabov AS. Stoyanova A, et al. Antivir Chem Chemother. 2015 Dec;24(5-6):136-147. doi: 10.1177/2040206616671571. Epub 2016 Nov 4. Antivir Chem Chemother. 2015. PMID: 27815331 Free PMC article.

70

Effect of sialidase fusion protein (DAS 181) on human metapneumovirus infection of Hep-2 cells.

Thammawat S, Sadlon TA, Adamson P, Gordon DL. Thammawat S, et al. Antivir Chem Chemother. 2015 Dec;24(5-6):161-165. doi: 10.1177/2040206616665971. Epub 2016 Sep 20. Antivir Chem Chemother. 2015. PMID: 27620888 Free PMC article.

71

Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivative.

Ito W, Toyama M, Okamoto M, Ikeda M, Watashi K, Wakita T, Hashimoto Y, Baba M. Ito W, et al. Antivir Chem Chemother. 2015 Dec;24(5-6):148-154. doi: 10.1177/2040206616663956. Epub 2016 Aug 19. Antivir Chem Chemother. 2015. PMID: 27503576 Free PMC article.

72

Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus.

Montiel M, Bonilla E, Valero N, Mosquera J, Espina LM, Quiroz Y, Álvarez-Mon M. Montiel M, et al. Antivir Chem Chemother. 2015 Aug;24(3-4):99-108. doi: 10.1177/2040206616660851. Epub 2016 Aug 8. Antivir Chem Chemother. 2015. PMID: 27503577 Free PMC article.

73

Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice.

Galabov AS, Mileva M, Simeonova L, Gegova G. Galabov AS, et al. Antivir Chem Chemother. 2015 Aug;24(3-4):83-91. doi: 10.1177/2040206616656263. Epub 2016 Jun 24. Antivir Chem Chemother. 2015. PMID: 27341844 Free PMC article.

74

Predicting Zika virus structural biology: Challenges and opportunities for intervention.

Cox BD, Stanton RA, Schinazi RF. Cox BD, et al. Antivir Chem Chemother. 2015 Aug;24(3-4):118-26. doi: 10.1177/2040206616653873. Epub 2016 Jun 13. Antivir Chem Chemother. 2015. PMID: 27296393 Free PMC article.

75

Derivatives of usnic acid inhibit broad range of influenza viruses and protect mice from lethal influenza infection.

Shtro AA, Zarubaev VV, Luzina OA, Sokolov DN, Salakhutdinov NF. Shtro AA, et al. Antivir Chem Chemother. 2015 Aug;24(3-4):92-8. doi: 10.1177/2040206616636992. Epub 2016 Mar 27. Antivir Chem Chemother. 2015. PMID: 27022094 Free PMC article.

76

Molecular basis of influenza hemagglutinin inhibition with an entry-blocker peptide by computational docking and mass spectrometry.

Lu R, Müller P, Downard KM. Lu R, et al. Antivir Chem Chemother. 2015 Aug;24(3-4):109-17. doi: 10.1177/2040206615622920. Epub 2016 Jan 12. Antivir Chem Chemother. 2015. PMID: 26759268 Free PMC article.

77

Anti-HIV-1 activity determined by β-galactosidase activity in the multinuclear activation of an indicator assay is comparable with that by a conventional focus counting method.

Miyamoto F, Kawaji K, Oishi S, Fujii N, Kaku M, Kodama EN. Miyamoto F, et al. Antivir Chem Chemother. 2015 Apr;24(2):77-82. doi: 10.1177/2040206615614164. Epub 2015 Nov 2. Antivir Chem Chemother. 2015. PMID: 26527820 Free PMC article.

78

Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives.

Sakakibara N, Balboni G, Congiu C, Onnis V, Demizu Y, Misawa T, Kurihara M, Kato Y, Maruyama T, Toyama M, Okamoto M, Baba M. Sakakibara N, et al. Antivir Chem Chemother. 2015 Apr;24(2):62-71. doi: 10.1177/2040206615612208. Epub 2015 Oct 28. Antivir Chem Chemother. 2015. PMID: 26514833 Free PMC article.

79

Prodrugs of herpes simplex thymidine kinase inhibitors.

Yanachkova M, Xu WC, Dvoskin S, Dix EJ, Yanachkov IB, Focher F, Savi L, Sanchez MD, Foster TP, Wright GE. Yanachkova M, et al. Antivir Chem Chemother. 2015 Apr;24(2):47-55. doi: 10.1177/2040206615608722. Epub 2015 Oct 13. Antivir Chem Chemother. 2015. PMID: 26463822 Free PMC article.

80

A two-week regimen of high-dose integrase inhibitors does not cause nephrotoxicity in mice.

Eadon MT, Zhang H, Skaar TC, Hato T, Dagher PC, Gupta SK, Desta Z. Eadon MT, et al. Antivir Chem Chemother. 2015 Apr;24(2):72-6. doi: 10.1177/2040206615595318. Epub 2015 Jul 30. Antivir Chem Chemother. 2015. PMID: 26229068 Free PMC article.

81

Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.

Bernard A, Lacroix C, Cabiddu MG, Neyts J, Leyssen P, Pompei R. Bernard A, et al. Antivir Chem Chemother. 2015 Apr;24(2):56-61. doi: 10.1177/2040206615589035. Epub 2015 Jun 11. Antivir Chem Chemother. 2015. PMID: 26071135 Free PMC article.

82

Influence of L-lysine amino acid on the HIV-1 RNA replication in vitro.

Butorov EV. Butorov EV. Antivir Chem Chemother. 2015 Feb;24(1):39-46. doi: 10.1177/2040206614566582. Antivir Chem Chemother. 2015. PMID: 26149265 Free PMC article.

83

Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor.

Han YS, Xiao WL, Xu H, Kramer VG, Quan Y, Mesplède T, Oliveira M, Colby-Germinario SP, Sun HD, Wainberg MA. Han YS, et al. Antivir Chem Chemother. 2015 Feb;24(1):28-38. doi: 10.1177/2040206614566580. Antivir Chem Chemother. 2015. PMID: 26149264 Free PMC article.

84

Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.

Bernstein DI, Bravo FJ, Pullum DA, Shen H, Wang M, Rahman A, Glazer RI, Cardin RD. Bernstein DI, et al. Antivir Chem Chemother. 2015 Feb;24(1):19-27. doi: 10.1177/2040206614566581. Antivir Chem Chemother. 2015. PMID: 26149263 Free PMC article.

85

Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.

Sakakibara N, Baba M, Okamoto M, Toyama M, Demizu Y, Misawa T, Kurihara M, Irie K, Kato Y, Maruyama T. Sakakibara N, et al. Antivir Chem Chemother. 2015 Feb;24(1):3-18. doi: 10.1177/2040206614566584. Antivir Chem Chemother. 2015. PMID: 26149262 Free PMC article.

86

AVCC 1990-2015--A journal to combine antiviral biology and antiviral chemistry enters the third era.

Field HJ. Field HJ. Antivir Chem Chemother. 2015 Feb;24(1):1-2. doi: 10.1177/2040206615574801. Antivir Chem Chemother. 2015. PMID: 26149261 Free PMC article. No abstract available.

87

Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs.

Clouser CL, Bonnac L, Mansky LM, Patterson SE. Clouser CL, et al. Antivir Chem Chemother. 2014 Dec 16;23(6):223-30. doi: 10.3851/IMP2682. Antivir Chem Chemother. 2014. PMID: 23994876 Free PMC article.

88

Myristoylated derivatives of 2',3'-didehydro-2',3'-dideoxythymidine (stavudine) bi-functional prodrugs with potent anti-HIV-1 activity and low cytotoxicity.

Singh RK, Miazga A, Dąbrowska A, Lipniacki A, Piasek A, Kulikowski T, Shugar D. Singh RK, et al. Antivir Chem Chemother. 2014 Dec 16;23(6):231-5. doi: 10.3851/IMP2679. Antivir Chem Chemother. 2014. PMID: 23985753 Free article.

89

Inhibition of novel reassortant avian influenza H7N9 virus infection in vitro with three antiviral drugs, oseltamivir, peramivir and favipiravir.

Cao RY, Xiao JH, Cao B, Li S, Kumaki Y, Zhong W. Cao RY, et al. Antivir Chem Chemother. 2014 Dec 16;23(6):237-40. doi: 10.3851/IMP2672. Antivir Chem Chemother. 2014. PMID: 23948557 Free article.

90

Recent findings on the mechanisms involved in tenofovir resistance.

Iyidogan P, Anderson KS. Iyidogan P, et al. Antivir Chem Chemother. 2014 Dec 16;23(6):217-22. doi: 10.3851/IMP2628. Antivir Chem Chemother. 2014. PMID: 23744599 Free PMC article. Review.

91

Small molecule inhibitors of West Nile virus.

Elseginy SA, Massarotti A, Nawwar GA, Amin KM, Brancale A. Elseginy SA, et al. Antivir Chem Chemother. 2014 Apr 11;23(5):179-87. doi: 10.3851/IMP2581. Antivir Chem Chemother. 2014. PMID: 23636899 Free article. Review.

92

Retinazone inhibits certain blood-borne human viruses including Ebola virus Zaire.

Kesel AJ, Huang Z, Murray MG, Prichard MN, Caboni L, Nevin DK, Fayne D, Lloyd DG, Detorio MA, Schinazi RF. Kesel AJ, et al. Antivir Chem Chemother. 2014 Apr 11;23(5):197-215. doi: 10.3851/IMP2568. Antivir Chem Chemother. 2014. PMID: 23636868 Free PMC article.

93

The application of prophylactic antibodies for rhinovirus infections.

Privolizzi R, Solari R, Johnston SL, McLean GR. Privolizzi R, et al. Antivir Chem Chemother. 2014 Apr 11;23(5):173-7. doi: 10.3851/IMP2578. Antivir Chem Chemother. 2014. PMID: 23598287 Free article. Review.

94

Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.

Bernstein DI, Cardin RD, Bravo FJ, Earwood J, Clark JR, Li Y, Mishra P, Li C, Nayak BP, Miller AT, Wu TY, Cooke MP, Valiante NM. Bernstein DI, et al. Antivir Chem Chemother. 2014 Apr 11;23(5):189-96. doi: 10.3851/IMP2499. Antivir Chem Chemother. 2014. PMID: 23232327 Free article.

95

Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors.

Manson McManamy ME, Hakre S, Verdin EM, Margolis DM. Manson McManamy ME, et al. Antivir Chem Chemother. 2014 Jan 29;23(4):145-9. doi: 10.3851/IMP2551. Antivir Chem Chemother. 2014. PMID: 24318952 Free PMC article. Review.

96

Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors.

Esposito F, Tramontano E. Esposito F, et al. Antivir Chem Chemother. 2014 Jan 29;23(4):129-44. doi: 10.3851/IMP2690. Antivir Chem Chemother. 2014. PMID: 24150519 Free article. Review.

97

Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.

Krajczyk A, Kulinska K, Kulinski T, Hurst BL, Day CW, Smee DF, Ostrowski T, Januszczyk P, Zeidler J. Krajczyk A, et al. Antivir Chem Chemother. 2014 Jan 29;23(4):161-71. doi: 10.3851/IMP2564. Antivir Chem Chemother. 2014. PMID: 23538746 Free article.

98

Activity of a phenolic dibenzylsulfide against New World arenavirus infections.

Gowen BB, Jung KH, Sefing EJ, Wong MH, Westover JB, Smee DF. Gowen BB, et al. Antivir Chem Chemother. 2014 Jan 29;23(4):151-9. doi: 10.3851/IMP2532. Antivir Chem Chemother. 2014. PMID: 23337126 Free PMC article.

99

Novel thiosialosides tethered to metal nanoparticles as potent influenza A virus haemagglutinin blockers.

Feng F, Sakoda Y, Ohyanagi T, Nagahori N, Shibuya H, Okamastu M, Miura N, Kida H, Nishimura S. Feng F, et al. Antivir Chem Chemother. 2013 May 16;23(2):59-65. doi: 10.3851/IMP2553. Antivir Chem Chemother. 2013. PMID: 23425865 Free article.

100

Antiviral drug development--success and failure: a personal perspective with a Japanese connection.

De Clercq E. De Clercq E. Antivir Chem Chemother. 2013 May 16;23(2):45-55. doi: 10.3851/IMP2396. Antivir Chem Chemother. 2013. PMID: 22992351 Free article. Review.

101

Professor De Clercq and 25 years of international collaboration on antiviral research.

Colacino JM. Colacino JM. Antivir Chem Chemother. 2013 May 16;23(2):57-8. doi: 10.3851/IMP2395. Antivir Chem Chemother. 2013. PMID: 22992324 Free article.

102

Selective anti-herpesvirus agents.

De Clercq E. De Clercq E. Antivir Chem Chemother. 2013 Jan 23;23(3):93-101. doi: 10.3851/IMP2533. Antivir Chem Chemother. 2013. PMID: 23343513 Free article. Review.

103

Antiviral agents derived from novel 1-adamantyl singlet nitrenes.

Kesel AJ, Weiss HC, Schönleber A, Day CW, Barnard DL, Detorio MA, Schinazi RF. Kesel AJ, et al. Antivir Chem Chemother. 2012 Dec 7;23(3):113-28. doi: 10.3851/IMP2485. Antivir Chem Chemother. 2012. PMID: 23234699 Free PMC article.

104

Herpes simplex virus-1 encephalitis: a review of current disease management with three case reports.

Skelly MJ, Burger AA, Adekola O. Skelly MJ, et al. Antivir Chem Chemother. 2012 Sep 25;23(1):13-8. doi: 10.3851/IMP2129. Antivir Chem Chemother. 2012. PMID: 23018202 Free article. Review.

105

Exploration of the in vitro antiviral activity of a series of new pyrimidine analogues on the replication of HIV and HCV.

Jafar NN, Al-Masoudi NA, Baqir SJ, Leyssen P, Pannecouque C. Jafar NN, et al. Antivir Chem Chemother. 2012 Sep 25;23(3):103-12. doi: 10.3851/IMP2400. Antivir Chem Chemother. 2012. PMID: 23010622 Free article.

106

Scientific report: highlights of 25th ICAR, 16-19 April 2012, Sapporo, Japan.

Hodge AV. Hodge AV. Antivir Chem Chemother. 2012 Sep 25;23(1):19-33. doi: 10.3851/IMP2384. Antivir Chem Chemother. 2012. PMID: 22976587 Free article.

107

The application and mechanism of action of ribavirin in therapy of hepatitis C.

Thomas E, Ghany MG, Liang TJ. Thomas E, et al. Antivir Chem Chemother. 2012 Sep 25;23(1):1-12. doi: 10.3851/IMP2125. Antivir Chem Chemother. 2012. PMID: 22592135 Free PMC article. Review.

108

D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.

Smee DF, Hurst BL, Day CW. Smee DF, et al. Antivir Chem Chemother. 2012 Aug 21;22(6):263-72. doi: 10.3851/IMP2105. Antivir Chem Chemother. 2012. PMID: 22516927 Free article.

109

Antiviral activity of recombinant mouse β-defensin 3 against influenza A virus in vitro and in vivo.

Jiang Y, Yang D, Li W, Wang B, Jiang Z, Li M. Jiang Y, et al. Antivir Chem Chemother. 2012 Aug 21;22(6):255-62. doi: 10.3851/IMP2077. Antivir Chem Chemother. 2012. PMID: 22345365 Free article.

110

Virus infection of the heart--unmet therapeutic needs.

Hazebroek M, Dennert R, Heymans S. Hazebroek M, et al. Antivir Chem Chemother. 2012 Aug 21;22(6):249-53. doi: 10.3851/IMP2047. Antivir Chem Chemother. 2012. PMID: 22293868 Free article. Review.

111

Influenza nucleoprotein: promising target for antiviral chemotherapy.

Cianci C, Gerritz SW, Deminie C, Krystal M. Cianci C, et al. Antivir Chem Chemother. 2012 Jul 26;23(3):77-91. doi: 10.3851/IMP2235. Antivir Chem Chemother. 2012. PMID: 22837443 Free article. Review.

112

Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.

Murray JL, McDonald NJ, Sheng J, Shaw MW, Hodge TW, Rubin DH, O'Brien WA, Smee DF. Murray JL, et al. Antivir Chem Chemother. 2012 May 14;22(5):205-15. doi: 10.3851/IMP2080. Antivir Chem Chemother. 2012. PMID: 22374988 Free article.

113

Phosphoramidate prodrugs of (-)-β-D-(2R,4R)-dioxolane-thymine (DOT) as potent anti-HIV agents.

Wang P, Rachakonda S, Zennou V, Keilman M, Niu C, Bao D, Ross BS, Furman PA, Otto MJ, Sofia MJ. Wang P, et al. Antivir Chem Chemother. 2012 May 14;22(5):217-38. doi: 10.3851/IMP2079. Antivir Chem Chemother. 2012. PMID: 22358223 Free article.

114

Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy.

Pertusati F, Serpi M, McGuigan C. Pertusati F, et al. Antivir Chem Chemother. 2012 May 14;22(5):181-203. doi: 10.3851/IMP2012. Antivir Chem Chemother. 2012. PMID: 22182785 Free article. Review.

115

Angiogenic activity of hepatitis B and C viruses.

Vrancken K, Paeshuyse J, Liekens S. Vrancken K, et al. Antivir Chem Chemother. 2012 Jan 17;22(4):159-70. doi: 10.3851/IMP1987. Antivir Chem Chemother. 2012. PMID: 22182803 Free article. Review.

116

Novel HIV-1 fusion inhibition peptides: designing the next generation of drugs.

Miyamoto F, Kodama EN. Miyamoto F, et al. Antivir Chem Chemother. 2012 Jan 17;22(4):151-8. doi: 10.3851/IMP1930. Antivir Chem Chemother. 2012. PMID: 22182762 Free article. Review.

117

The prophylaxis and treatment with antiviral agents of respiratory syncytial virus infections.

Najarro P, Angell R, Powell K. Najarro P, et al. Antivir Chem Chemother. 2012 Jan 17;22(4):139-50. doi: 10.3851/IMP1873. Antivir Chem Chemother. 2012. PMID: 22182737 Free article. Review.

118

Antiviral treatment of calves persistently infected with bovine viral diarrhoea virus.

Newcomer BW, Marley MS, Galik PK, Walz PH, Zhang Y, Riddell KP, Dykstra CC, Boykin DW, Kumar A, Cruz-Espindola C, Boothe DM, Joiner KS, Givens MD. Newcomer BW, et al. Antivir Chem Chemother. 2012 Jan 17;22(4):171-9. doi: 10.3851/IMP1903. Antivir Chem Chemother. 2012. PMID: 22182713 Free article. Clinical Trial.

119

Efficacy of orally administered low dose N-methanocarbathymidine against lethal herpes simplex virus type-2 infections of mice.

Quenelle DC, Collins DJ, Rice TL, Rahman A, Glazer R. Quenelle DC, et al. Antivir Chem Chemother. 2011 Nov 17;22(3):131-7. doi: 10.3851/IMP1901. Antivir Chem Chemother. 2011. PMID: 22095521 Free article.

120

Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.

Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T. Jiang H, et al. Antivir Chem Chemother. 2011 Nov 17;22(3):119-30. doi: 10.3851/IMP1902. Antivir Chem Chemother. 2011. PMID: 22095520 Free article.

121

Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates.

Samuele A, Bisi S, Kataropoulou A, La Regina G, Piscitelli F, Gatti V, Silvestri R, Maga G. Samuele A, et al. Antivir Chem Chemother. 2011 Nov 17;22(3):107-18. doi: 10.3851/IMP1855. Antivir Chem Chemother. 2011. PMID: 22095519 Free article.

122

HIV-1 integrase inhibitors: a review of their chemical development.

Ingale KB, Bhatia MS. Ingale KB, et al. Antivir Chem Chemother. 2011 Nov 17;22(3):95-105. doi: 10.3851/IMP1740. Antivir Chem Chemother. 2011. PMID: 22095518 Free article. Review.

123

Scientific report: highlights of 24th ICAR, 8-11 May 2011, Sofia, Bulgaria.

Vere Hodge A. Vere Hodge A. Antivir Chem Chemother. 2011 Oct 7;22(2):75-85. doi: 10.3851/IMP1885. Antivir Chem Chemother. 2011. PMID: 21984687 Free article.

124

Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds.

Sudol M, Fritz JL, Tran M, Robertson GP, Ealy JB, Katzman M. Sudol M, et al. Antivir Chem Chemother. 2011 Oct 7;22(2):67-74. doi: 10.3851/IMP1857. Antivir Chem Chemother. 2011. PMID: 21984686 Free PMC article.

125

Synthesis of 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives with potential anti-HIV activity.

Isono Y, Sakakibara N, Ordonez P, Hamasaki T, Baba M, Ikejiri M, Maruyama T. Isono Y, et al. Antivir Chem Chemother. 2011 Oct 7;22(2):57-65. doi: 10.3851/IMP1844. Antivir Chem Chemother. 2011. PMID: 21984685 Free article.

126

Potent anti-HIV-1 activity of N-HR-derived peptides including a deep pocket-forming region without antagonistic effects on T-20.

Izumi K, Watanabe K, Oishi S, Fujii N, Matsuoka M, Sarafianos SG, Kodama EN. Izumi K, et al. Antivir Chem Chemother. 2011 Aug 23;22(1):51-5. doi: 10.3851/IMP1836. Antivir Chem Chemother. 2011. PMID: 21860071 Free PMC article.

127

Nucleotide prodrugs for HCV therapy.

Sofia MJ. Sofia MJ. Antivir Chem Chemother. 2011 Aug 23;22(1):23-49. doi: 10.3851/IMP1797. Antivir Chem Chemother. 2011. PMID: 21860070 Free article. Review.

128

The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.

Zhu Y, Curtis M, Borroto-Esoda K. Zhu Y, et al. Antivir Chem Chemother. 2011 Aug 23;22(1):13-22. doi: 10.3851/IMP1791. Antivir Chem Chemother. 2011. PMID: 21860069 Free article.

129

Anti-influenza virus activity of tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone.

Yazawa K, Kurokawa M, Obuchi M, Li Y, Yamada R, Sadanari H, Matsubara K, Watanabe K, Koketsu M, Tuchida Y, Murayama T. Yazawa K, et al. Antivir Chem Chemother. 2011 Aug 23;22(1):1-11. doi: 10.3851/IMP1782. Antivir Chem Chemother. 2011. PMID: 21860068 Free article.

130

Epigallocatechin gallate inhibits the HIV reverse transcription step.

Li S, Hattori T, Kodama EN. Li S, et al. Antivir Chem Chemother. 2011 Jul 4;21(6):239-43. doi: 10.3851/IMP1774. Antivir Chem Chemother. 2011. PMID: 21730371 Free article.

131

Effects of TheraMax on influenza virus infections in cell culture and in mice.

Smee DF, Hurst BL, Wong MH. Smee DF, et al. Antivir Chem Chemother. 2011 Jul 4;21(6):231-7. doi: 10.3851/IMP1744. Antivir Chem Chemother. 2011. PMID: 21730370 Free article.

132

Novel 1,2,4-triazole and purine acyclic cyclopropane nucleoside analogues: synthesis, antiviral and cytostatic activity evaluations.

Benci K, Suhina T, Mandić L, Pavelić SK, Paravić AT, Pavelić K, Balzarini J, Wittine K, Mintas M. Benci K, et al. Antivir Chem Chemother. 2011 Jul 4;21(6):221-30. doi: 10.3851/IMP1762. Antivir Chem Chemother. 2011. PMID: 21730369 Free article.

133

William H Prusoff dies at 90 - a renaissance man that revolutionized the treatment of herpesviruses and HIV.

Schinazi RF. Schinazi RF. Antivir Chem Chemother. 2011 Jul 4;21(6):219-20. doi: 10.3851/IMP1827. Antivir Chem Chemother. 2011. PMID: 21730368 Free article. No abstract available.

134

Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.

Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, Wong TA, Margosiak SA. Cregar-Hernandez L, et al. Antivir Chem Chemother. 2011 May 12;21(5):209-17. doi: 10.3851/IMP1767. Antivir Chem Chemother. 2011. PMID: 21566267 Free PMC article.

135

Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances.

Smee DF, Bailey KW, Wong MH, Tarbet EB. Smee DF, et al. Antivir Chem Chemother. 2011 May 12;21(5):201-8. doi: 10.3851/IMP1734. Antivir Chem Chemother. 2011. PMID: 21566266 Free article.

136

Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir.

Buys KK, Jung KH, Smee DF, Furuta Y, Gowen BB. Buys KK, et al. Antivir Chem Chemother. 2011 May 12;21(5):193-200. doi: 10.3851/IMP1729. Antivir Chem Chemother. 2011. PMID: 21566265 Free PMC article.

137

Antiviral pharmacodynamics in hollow fibre bioreactors.

McSharry JJ, Drusano GL. McSharry JJ, et al. Antivir Chem Chemother. 2011 May 12;21(5):183-92. doi: 10.3851/IMP1770. Antivir Chem Chemother. 2011. PMID: 21566264 Free article. Review.

138

Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus.

Zhirnov OP, Matrosovich TY, Matrosovich MN, Klenk HD. Zhirnov OP, et al. Antivir Chem Chemother. 2011 Mar 7;21(4):169-74. doi: 10.3851/IMP1715. Antivir Chem Chemother. 2011. PMID: 21602614 Free article.

139

Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design.

Rhodes DI, Peat TS, Vandegraaff N, Jeevarajah D, Le G, Jones ED, Smith JA, Coates JA, Winfield LJ, Thienthong N, Newman J, Lucent D, Ryan JH, Savage GP, Francis CL, Deadman JJ. Rhodes DI, et al. Antivir Chem Chemother. 2011 Mar 7;21(4):155-68. doi: 10.3851/IMP1716. Antivir Chem Chemother. 2011. PMID: 21602613 Free article.

140

Peptide inhibitors against influenza virus.

Rajik M, Yusoff K. Rajik M, et al. Antivir Chem Chemother. 2011 Mar 7;21(4):151-4. doi: 10.3851/IMP1728. Antivir Chem Chemother. 2011. PMID: 21602612 Free article.

141

Synthesis and an antiviral activity evaluation of nucleoside 5´-O-(N-acyl) phosphoramidates.

Kulik K, Radzikowska E, Kaczmarek R, Baraniak J, Stec WJ, De Clercq E, Balzarini J, Pannecouque C. Kulik K, et al. Antivir Chem Chemother. 2011;21(3):143-50. doi: 10.3851/IMP1718. Antivir Chem Chemother. 2011. PMID: 21233535 Free article.

142

Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acids.

Trippier PC, Balzarini J, McGuigan C. Trippier PC, et al. Antivir Chem Chemother. 2011;21(3):129-42. doi: 10.3851/IMP1707. Antivir Chem Chemother. 2011. PMID: 21233534 Free article.

143

Therapeutic targeting of HCV internal ribosomal entry site RNA.

Davis DR, Seth PP. Davis DR, et al. Antivir Chem Chemother. 2011;21(3):117-28. doi: 10.3851/IMP1693. Antivir Chem Chemother. 2011. PMID: 21233533 Free article. Review.

144

Important advances in the field of anti-dengue virus research.

Julander JG, Perry ST, Shresta S. Julander JG, et al. Antivir Chem Chemother. 2011;21(3):105-16. doi: 10.3851/IMP1690. Antivir Chem Chemother. 2011. PMID: 21233532 Free article. Review.

145

In vitro and in vivo anti-influenza virus activity of diarylheptanoids isolated from Alpinia officinarum.

Sawamura R, Shimizu T, Sun Y, Yasukawa K, Miura M, Toriyama M, Motohashi S, Watanabe W, Konno K, Kurokawa M. Sawamura R, et al. Antivir Chem Chemother. 2010 Oct 28;21(1):33-41. doi: 10.3851/IMP1676. Antivir Chem Chemother. 2010. PMID: 21045258 Free article.

146

Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue.

Derudas M, Quintiliani M, Brancale A, Andrei G, Snoeck R, Balzarini J, McGuigan C. Derudas M, et al. Antivir Chem Chemother. 2010 Oct 28;21(1):15-31. doi: 10.3851/IMP1661. Antivir Chem Chemother. 2010. PMID: 21045257 Free article.

147

Nano-NRTIs: efficient inhibitors of HIV type-1 in macrophages with a reduced mitochondrial toxicity.

Vinogradov SV, Poluektova LY, Makarov E, Gerson T, Senanayake MT. Vinogradov SV, et al. Antivir Chem Chemother. 2010 Oct 28;21(1):1-14. doi: 10.3851/IMP1680. Antivir Chem Chemother. 2010. PMID: 21045256 Free PMC article.

148

Synthesis and biological evaluation of heat-shock protein 90 inhibitors: geldanamycin derivatives with broad antiviral activities.

Li YP, Shan GZ, Peng ZG, Zhu JH, Meng S, Zhang T, Gao LY, Tao PZ, Gao RM, Li YH, Jiang JD, Li ZR. Li YP, et al. Antivir Chem Chemother. 2010 Aug 11;20(6):259-68. doi: 10.3851/IMP1631. Antivir Chem Chemother. 2010. PMID: 20710066 Free article.

149

Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: monophenylboronic acids.

Trippier PC, McGuigan C, Balzarini J. Trippier PC, et al. Antivir Chem Chemother. 2010 Aug 11;20(6):249-57. doi: 10.3851/IMP1632. Antivir Chem Chemother. 2010. PMID: 20710065 Free article.

150

Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication.

Li S, Kodama EN, Inoue Y, Tani H, Matsuura Y, Zhang J, Tanaka T, Hattori T. Li S, et al. Antivir Chem Chemother. 2010 Aug 11;20(6):239-48. doi: 10.3851/IMP1597. Antivir Chem Chemother. 2010. PMID: 20710064 Free article.

151

Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors.

La Regina G, Coluccia A, Silvestri R. La Regina G, et al. Antivir Chem Chemother. 2010 Aug 11;20(6):213-37. doi: 10.3851/IMP1607. Antivir Chem Chemother. 2010. PMID: 20710063 Free article. Review.

152

Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice.

Smee DF, Hurst BL, Wong MH. Smee DF, et al. Antivir Chem Chemother. 2010 Apr 14;20(5):201-5. doi: 10.3851/IMP1480. Antivir Chem Chemother. 2010. PMID: 20413827 Free article.

153

Anti-bovine viral diarrhoea virus activity of novel diphenylmethane derivatives.

Salim MT, Okamoto M, Hosoda S, Aoyama H, Hashimoto Y, Baba M. Salim MT, et al. Antivir Chem Chemother. 2010 Apr 14;20(5):193-200. doi: 10.3851/IMP1528. Antivir Chem Chemother. 2010. PMID: 20413826 Free article.

154

CCR5 antagonists: host-targeted antiviral agents for the treatment of HIV infection, 4 years on.

Westby M, van der Ryst E. Westby M, et al. Antivir Chem Chemother. 2010 Apr 14;20(5):179-92. doi: 10.3851/IMP1507. Antivir Chem Chemother. 2010. PMID: 20413825 Free article. Review.

155

Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice.

Kumaki Y, Day CW, Bailey KW, Wandersee MK, Wong MH, Madsen JR, Madsen JS, Nelson NM, Hoopes JD, Woolcott JD, McLean TZ, Blatt LM, Salazar AM, Smee DF, Barnard DL. Kumaki Y, et al. Antivir Chem Chemother. 2010 Mar 9;20(4):169-77. doi: 10.3851/IMP1477. Antivir Chem Chemother. 2010. PMID: 20231782 Free article.

156

Combination therapy for hepatitis C virus with heat-shock protein 90 inhibitor 17-AAG and proteasome inhibitor MG132.

Ujino S, Yamaguchi S, Shimotohno K, Takaku H. Ujino S, et al. Antivir Chem Chemother. 2010 Mar 9;20(4):161-7. doi: 10.3851/IMP1479. Antivir Chem Chemother. 2010. PMID: 20231781 Free article.

157

The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTides.

Mehellou Y, Balzarini J, McGuigan C. Mehellou Y, et al. Antivir Chem Chemother. 2010 Mar 9;20(4):153-60. doi: 10.3851/IMP1476. Antivir Chem Chemother. 2010. PMID: 20231780 Free article.

158

Advanced in silico approaches in antiviral research.

Zonta N, Coluccia A, Brancale A. Zonta N, et al. Antivir Chem Chemother. 2010 Mar 9;20(4):147-51. doi: 10.3851/IMP1500. Antivir Chem Chemother. 2010. PMID: 20231779 Free article.

159

Activity of isatine-sulfadimidine derivatives against 2009 pandemic H1N1 influenza virus in cell culture.

Selvam P, Chandramohan M, Hurst BL, Smee DF. Selvam P, et al. Antivir Chem Chemother. 2010 Jan 5;20(3):143-6. doi: 10.3851/IMP1471. Antivir Chem Chemother. 2010. PMID: 20054101 Free article.

160

The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.

Holcakova J, Tomasec P, Bugert JJ, Wang EC, Wilkinson GW, Hrstka R, Krystof V, Strnad M, Vojtesek B. Holcakova J, et al. Antivir Chem Chemother. 2010 Jan 5;20(3):133-42. doi: 10.3851/IMP1460. Antivir Chem Chemother. 2010. PMID: 20054100 Free PMC article.

161

Factors affecting template usage in the development of K65R resistance in subtype C variants of HIV type-1.

Coutsinos D, Invernizzi CF, Xu H, Brenner BG, Wainberg MA. Coutsinos D, et al. Antivir Chem Chemother. 2010 Jan 5;20(3):117-31. doi: 10.3851/IMP1443. Antivir Chem Chemother. 2010. PMID: 20054099 Free article.

162

FV-100: the most potent and selective anti-varicella zoster virus agent reported to date.

Migliore M. Migliore M. Antivir Chem Chemother. 2010 Jan 5;20(3):107-15. doi: 10.3851/IMP1472. Antivir Chem Chemother. 2010. PMID: 20054098 Free article. Review.

163

Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture.

Ying C, Tan S, Cheng YC. Ying C, et al. Antivir Chem Chemother. 2010;21(2):97-103. doi: 10.3851/IMP1686. Antivir Chem Chemother. 2010. PMID: 21107018 Free article.

164

Anti-cytomegalovirus activity of sulfated glucans generated from a commercial preparation of rice bran.

Ghosh T, Auerochs S, Saha S, Ray B, Marschall M. Ghosh T, et al. Antivir Chem Chemother. 2010;21(2):85-95. doi: 10.3851/IMP1685. Antivir Chem Chemother. 2010. PMID: 21107017 Free article.

165

Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza.

Yamashita M. Yamashita M. Antivir Chem Chemother. 2010;21(2):71-84. doi: 10.3851/IMP1688. Antivir Chem Chemother. 2010. PMID: 21107016 Free article. Review.

166

Nanoparticulate delivery systems for antiviral drugs.

Lembo D, Cavalli R. Lembo D, et al. Antivir Chem Chemother. 2010;21(2):53-70. doi: 10.3851/IMP1684. Antivir Chem Chemother. 2010. PMID: 21107015 Free article. Review.

167

Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.

Rondla R, Coats SJ, McBrayer TR, Grier J, Johns M, Tharnish PM, Whitaker T, Zhou L, Schinazi RF. Rondla R, et al. Antivir Chem Chemother. 2009 Oct 19;20(2):99-106. doi: 10.3851/IMP1400. Antivir Chem Chemother. 2009. PMID: 19843980 Free PMC article.

168

Inhibition of herpes simplex virus by polyamines.

Yudovin-Farber I, Gurt I, Hope R, Domb AJ, Katz E. Yudovin-Farber I, et al. Antivir Chem Chemother. 2009 Oct 19;20(2):87-98. doi: 10.3851/IMP1401. Antivir Chem Chemother. 2009. PMID: 19843979 Free article.

169

Elvitegravir: a new HIV integrase inhibitor.

Shimura K, Kodama EN. Shimura K, et al. Antivir Chem Chemother. 2009 Oct 19;20(2):79-85. doi: 10.3851/IMP1397. Antivir Chem Chemother. 2009. PMID: 19843978 Free article. Review.

170

Antiretroviral therapy in macrophages: implication for HIV eradication.

Gavegnano C, Schinazi RF. Gavegnano C, et al. Antivir Chem Chemother. 2009 Oct 19;20(2):63-78. doi: 10.3851/IMP1374. Antivir Chem Chemother. 2009. PMID: 19843977 Free PMC article. Review.

171

Anti-bovine viral diarrhoea virus and hepatitis C virus activity of the cyclooxygenase inhibitor SC-560.

Okamoto M, Sakai M, Goto Y, Salim MT, Baba C, Goto K, Watashi K, Shimotohno K, Baba M. Okamoto M, et al. Antivir Chem Chemother. 2009 Sep 25;20(1):47-54. doi: 10.3851/IMP1372. Antivir Chem Chemother. 2009. PMID: 19794231 Free article.

172

L-valine ester of cyclopropavir: a new antiviral prodrug.

Wu Z, Drach JC, Prichard MN, Yanachkova M, Yanachkov I, Bowlin TL, Zemlicka J. Wu Z, et al. Antivir Chem Chemother. 2009 Sep 25;20(1):37-46. doi: 10.3851/IMP782. Antivir Chem Chemother. 2009. PMID: 19794230 Free PMC article.

173

Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor.

Chen Y, Bopda-Waffo A, Basu A, Krishnan R, Silberstein E, Taylor DR, Talele TT, Arora P, Kaushik-Basu N. Chen Y, et al. Antivir Chem Chemother. 2009 Sep 25;20(1):19-36. doi: 10.3851/IMP1286. Antivir Chem Chemother. 2009. PMID: 19794229 Free article.

174

Current peptide HIV type-1 fusion inhibitors.

Pang W, Tam SC, Zheng YT. Pang W, et al. Antivir Chem Chemother. 2009 Sep 25;20(1):1-18. doi: 10.3851/IMP1369. Antivir Chem Chemother. 2009. PMID: 19794228 Free article. Review.

175

Effect of duration and intensity of ganciclovir exposure on lymphoblastoid cell toxicity.

Janoly-Dumenil A, Rouvet I, Bleyzac N, Bertrand Y, Aulagner G, Zabot MT. Janoly-Dumenil A, et al. Antivir Chem Chemother. 2009;19(6):257-62. doi: 10.1177/095632020901900605. Antivir Chem Chemother. 2009. PMID: 19641234 Free article.

176

HIV type-1 entry inhibitors with a new mode of action.

Fink RC, Roschek B Jr, Alberte RS. Fink RC, et al. Antivir Chem Chemother. 2009;19(6):243-55. doi: 10.1177/095632020901900604. Antivir Chem Chemother. 2009. PMID: 19641233 Free article.

177

Sulfated xylomannans from the red seaweed Sebdenia polydactyla: structural features, chemical modification and antiviral activity.

Ghosh T, Pujol CA, Damonte EB, Sinha S, Ray B. Ghosh T, et al. Antivir Chem Chemother. 2009;19(6):235-42. doi: 10.1177/095632020901900603. Antivir Chem Chemother. 2009. PMID: 19641232 Free article.

178

RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.

von Eije KJ, Berkhout B. von Eije KJ, et al. Antivir Chem Chemother. 2009;19(6):221-33. doi: 10.1177/095632020901900602. Antivir Chem Chemother. 2009. PMID: 19641231 Free article. Review.

179

From print to web: a landmark transition after 20 years of publishing.

Field HJ, Galea MN. Field HJ, et al. Antivir Chem Chemother. 2009;19(6):219-20. doi: 10.1177/095632020901900601. Antivir Chem Chemother. 2009. PMID: 19641230 Free article. No abstract available.

180

Mesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activity.

Mickleburgh I, Geng F, Tiley L. Mickleburgh I, et al. Antivir Chem Chemother. 2009;19(5):213-8. doi: 10.1177/095632020901900504. Antivir Chem Chemother. 2009. PMID: 19483269 Free article.

181

Synthesis and antiviral evaluation of 4'-alkoxy analogues of 9-(beta-D-xylofuranosyl)adenine.

Kubota Y, Ishizaki N, Kaneda Y, Haraguchi K, Odanaka Y, Tanaka H, Kato N, Baba M, Balzarini J. Kubota Y, et al. Antivir Chem Chemother. 2009;19(5):201-12. doi: 10.1177/095632020901900503. Antivir Chem Chemother. 2009. PMID: 19483268 Free article.

182

Novel compounds for the treatment of HIV type-1 infection.

Stellbrink HJ. Stellbrink HJ. Antivir Chem Chemother. 2009;19(5):189-200. doi: 10.1177/095632020901900502. Antivir Chem Chemother. 2009. PMID: 19483267 Free article. Review.

183

HIV type-1 latency: targeted induction of proviral reservoirs.

Graci JD, Colacino JM, Peltz SW, Dougherty JP, Gu Z. Graci JD, et al. Antivir Chem Chemother. 2009;19(5):177-87. doi: 10.1177/095632020901900501. Antivir Chem Chemother. 2009. PMID: 19483266 Free article. Review.

184

Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.

Zhu Y, Curtis M, Qi X, Miller MD, Borroto-Esoda K. Zhu Y, et al. Antivir Chem Chemother. 2009;19(4):165-76. doi: 10.1177/095632020901900404. Antivir Chem Chemother. 2009. PMID: 19374144 Free article.

185

HIV dynamics and integrase inhibitors.

Murray JM. Murray JM. Antivir Chem Chemother. 2009;19(4):157-64. doi: 10.1177/095632020901900403. Antivir Chem Chemother. 2009. PMID: 19374143 Free article.

186

Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme.

Chen X, Chou CY, Chang GG. Chen X, et al. Antivir Chem Chemother. 2009;19(4):151-6. doi: 10.1177/095632020901900402. Antivir Chem Chemother. 2009. PMID: 19374142 Free article.

187

The future of HIV microbicides: challenges and opportunities.

Garg AB, Nuttall J, Romano J. Garg AB, et al. Antivir Chem Chemother. 2009;19(4):143-50. doi: 10.1177/095632020901900401. Antivir Chem Chemother. 2009. PMID: 19374141 Free article. Review.

188

Binding modes of two novel non-nucleoside reverse transcriptase inhibitors, YM-215389 and YM-228855, to HIV type-1 reverse transcriptase.

Kodama E, Orita M, Masuda N, Yamomoto O, Fujii M, Ohgami T, Kageyama S, Ohta M, Hatta T, Inoue H, Suzuki H, Sudo K, Shimizu Y, Matsuoka M. Kodama E, et al. Antivir Chem Chemother. 2008;19(3):133-41. doi: 10.1177/095632020801900304. Antivir Chem Chemother. 2008. PMID: 19024630 Free article.

189

Anti-human cytomegalovirus activity of constituents from Sasa albo-marginata (Kumazasa in Japan).

Sakai A, Watanabe K, Koketsu M, Akuzawa K, Yamada R, Li Z, Sadanari H, Matsubara K, Muroyama T. Sakai A, et al. Antivir Chem Chemother. 2008;19(3):125-32. doi: 10.1177/095632020801900303. Antivir Chem Chemother. 2008. PMID: 19024629 Free article.

190

Progress in the discovery of compounds inhibiting orthopoxviruses in animal models.

Smee DF. Smee DF. Antivir Chem Chemother. 2008;19(3):115-24. doi: 10.1177/095632020801900302. Antivir Chem Chemother. 2008. PMID: 19024628 Free article. Review.

191

Bevirimat: a novel maturation inhibitor for the treatment of HIV-1 infection.

Martin DE, Salzwedel K, Allaway GP. Martin DE, et al. Antivir Chem Chemother. 2008;19(3):107-13. doi: 10.1177/095632020801900301. Antivir Chem Chemother. 2008. PMID: 19024627 Free article. Review.

192

Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.

De Clercq E, Field HJ. De Clercq E, et al. Antivir Chem Chemother. 2008;19(2):75-105. doi: 10.1177/095632020801900205. Antivir Chem Chemother. 2008. PMID: 18727442 Free article.

193

Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses.

De Clercq E, Field HJ. De Clercq E, et al. Antivir Chem Chemother. 2008;19(2):63-74. doi: 10.1177/095632020801900204. Antivir Chem Chemother. 2008. PMID: 18727441 Free article.

194

Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses.

Field HJ, De Clercq E. Field HJ, et al. Antivir Chem Chemother. 2008;19(2):51-62. doi: 10.1177/095632020801900203. Antivir Chem Chemother. 2008. PMID: 18727440 Free article.

195

Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition).

Field HJ. Field HJ. Antivir Chem Chemother. 2008;19(2):49-50. doi: 10.1177/095632020801900202. Antivir Chem Chemother. 2008. PMID: 18727439 Free article. No abstract available.

196

Synthesis and evaluation of N-substituted acridones as antiviral agents against haemorrhagic fever viruses.

Sepúlveda CS, Fascio ML, Mazzucco MB, Palacios ML, Pellón RF, García CC, D'Accorso NB, Damonte EB. Sepúlveda CS, et al. Antivir Chem Chemother. 2008;19(1):41-7. doi: 10.1177/095632020801900106. Antivir Chem Chemother. 2008. PMID: 18610557 Free article.

197

Antiviral activity of geneticin against bovine viral diarrhoea virus.

Birk AV, Dubovi EJ, Zhang X, Szeto HH. Birk AV, et al. Antivir Chem Chemother. 2008;19(1):33-40. doi: 10.1177/095632020801900105. Antivir Chem Chemother. 2008. PMID: 18610556 Free article.

198

Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system.

Bassit L, Grier J, Bennett M, Schinazi RF. Bassit L, et al. Antivir Chem Chemother. 2008;19(1):25-31. doi: 10.1177/095632020801900104. Antivir Chem Chemother. 2008. PMID: 18610555 Free PMC article.

199

Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus.

Smee DF, Humphreys DE, Hurst BL, Barnard DL. Smee DF, et al. Antivir Chem Chemother. 2008;19(1):15-24. doi: 10.1177/095632020801900103. Antivir Chem Chemother. 2008. PMID: 18610554 Free article.

200

Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice.

Shimizu T, Hino A, Tsutsumi A, Park YK, Watanabe W, Kurokawa M. Shimizu T, et al. Antivir Chem Chemother. 2008;19(1):7-13. doi: 10.1177/095632020801900102. Antivir Chem Chemother. 2008. PMID: 18610553 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

575 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

575 results

Results by year